A Comparative Study of the Efficacy of Penciclovir 10mg/g (1%) Cream in Preventing the Appearance of Classical Lesion in Recurrent Cold Sore Sufferers

PHASE4CompletedINTERVENTIONAL
Enrollment

126

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Cold Sore
Interventions
DRUG

Penciclovir

Penciclovir every 2 hours during waking hours for 96 hours

DRUG

Placebo

Placebo every 2 hous during waking hours for 96 hours

Trial Locations (1)

BT12 6BA

Belfast Health and Social Care Trust, Royal Victoria Hospital, Belfast

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY